Attached files
file | filename |
---|---|
EX-99.1 - WINNER MEDICAL GROUP INC | v204918_ex99-1.htm |
UNITED
STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
The
Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): December 8, 2010
WINNER
MEDICAL GROUP INC.
(Exact
Name of Registrant as Specified in its Charter)
Nevada
|
001-34484
|
33-0215298
|
||
(State
or other jurisdiction of
incorporation
or organization)
|
(Commission
File Number)
|
(I.R.S.
Employer
Identification
No.)
|
Winner
Industrial Park, Bulong Road
Longhua,
Shenzhen City, 518109
The
People’s Republic of China
(Address
of principal executive offices, including zip code)
(86)
755 2813-8888
(Registrant’s
telephone number, including area code)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
2.02 Results of Operations and Financial Conditions
On
December 8, 2010, Winner Medical Group Inc. (the “Company”) issued a press
release announcing its results for the fourth quarter and fiscal year ended
September 30, 2010. The press release is attached as Exhibit 99.1 to
this report on Form 8-K.
The
information in this Current Report on Form 8-K, including the press release
appearing in Exhibit 99.1, is furnished and shall not be deemed to be “filed”
for the purposes of Section 18 of the Securities Exchange Act of 1934, as
amended, or otherwise subject to the liability of that
section. Furthermore, the information in this Current Report on Form
8-K, including the press release appearing in Exhibit 99.1, shall not be deemed
to be incorporated by reference into the filings of the Company under the
Securities Act of 1933, as amended.
Item
9.01
|
Financial
Statements and Exhibits
|
(d)
|
Exhibits
|
Exhibit
No
|
Description
|
99.1
|
Press
Release of Winner Medical Group Inc., dated December 8,
2010.
|
2
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the
Company has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Winner
Medical Group Inc.
|
|||
Date:
|
December
8, 2010
|
By:
|
/s/
Jianquan
Li
|
Jianquan
Li
|
|||
President
and Chief Executive
Officer
|
3